Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheriza Baksh

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Journal of Environmental Health|November 21, 2017
Building the Future of Environmental Public Health Tracking: Proceedings and Recommendations of an Expert Panel WorkshopMary A Fox, Sheriza Baksh, Juleen Lam, et al.
JAMA Internal Medicine|August 15, 2018
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 DiabetesHsien-Yen Chang, Sonal Singh, Omar Mansour, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMaansi Barnwal, Sheriza Baksh, David Shade, et al.
Environmental Research|August 6, 2025
Impact of ambient ozone exposure on cardiac biomarkers in heart failure and the role of Sodium-glucose cotransporter-2 inhibitors: Findings from the TRACER-HF trialGang Li, Yunxing Jiang, Hongbing Xu, et al.
Scientific Reports|August 18, 2021
Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort studySheriza Baksh, Jiajun Wen, Omar Mansour, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 21, 2026
Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitationMaansi Barnwal, Sheriza Baksh, Zahinoor Ismail, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsPaul B Rosenberg, Carol A Manning, Anton P Porsteinsson, et al.
Ophthalmology|October 12, 2025
Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial, Douglas A Jabs, Elizabeth A Sugar, et al.
Trials|September 28, 2021
Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trialSheriza Baksh, Anne Casper, Mindy S Christianson, et al.
The Lancet Regional Health. Southeast Asia|February 18, 2026
Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective studyKunchok Dorjee, Sonam Topgyal, Rajesh K Sood, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Journal of Environmental Health|November 21, 2017
Building the Future of Environmental Public Health Tracking: Proceedings and Recommendations of an Expert Panel WorkshopMary A Fox, Sheriza Baksh, Juleen Lam, et al.
JAMA Internal Medicine|August 15, 2018
Association Between Sodium-Glucose Cotransporter 2 Inhibitors and Lower Extremity Amputation Among Patients With Type 2 DiabetesHsien-Yen Chang, Sonal Singh, Omar Mansour, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMaansi Barnwal, Sheriza Baksh, David Shade, et al.
Environmental Research|August 6, 2025
Impact of ambient ozone exposure on cardiac biomarkers in heart failure and the role of Sodium-glucose cotransporter-2 inhibitors: Findings from the TRACER-HF trialGang Li, Yunxing Jiang, Hongbing Xu, et al.
Scientific Reports|August 18, 2021
Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort studySheriza Baksh, Jiajun Wen, Omar Mansour, et al.
Alzheimer'S & Dementia (New York, N. Y.)|January 21, 2026
Blood biomarkers for Alzheimer's disease are correlated with measures of agitation and cognition in a randomized trial assessing the effects of escitalopram on agitationMaansi Barnwal, Sheriza Baksh, Zahinoor Ismail, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
Clinical ManifestationsPaul B Rosenberg, Carol A Manning, Anton P Porsteinsson, et al.
Ophthalmology|October 12, 2025
Adalimumab versus Conventional Immunosuppression for Uveitis (ADVISE) Trial, Douglas A Jabs, Elizabeth A Sugar, et al.
Trials|September 28, 2021
Natural vs. programmed cycles for frozen embryo transfer: study protocol for an investigator-initiated, randomized, controlled, multicenter clinical trialSheriza Baksh, Anne Casper, Mindy S Christianson, et al.
The Lancet Regional Health. Southeast Asia|February 18, 2026
Comprehensive tuberculosis screening and preventive treatment in schools and congregate settings of India (2017-2024): a prospective studyKunchok Dorjee, Sonam Topgyal, Rajesh K Sood, et al.
Pageof 2